Pfizer to Partner with Russia Drugmaker Polysan to Reach Local Market, Sources

Source: TASS

Jan 21, 2016

U.S.-based Pfizer will soon launch a joint production with Russian scientific and technological pharmaceutical company, Polysan, says Russian media sources.

According to TASS news agency, the agreement, which should be signed January 25, involves Pfizer producing its meds in Polysan's St. Petersburg facility.

Polysan is already producing four of its own drugs, as well as a neurological drug in partnership with German Stada, from its Petersburg site.

Read the TASS article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments